Trials / Completed
CompletedNCT07264465
A Clinical Trial to Evaluate the Effects of a Chickpea Pasta on Gut Health, Blood Glucose, and Overall Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Banza LLC · Industry
- Sex
- All
- Age
- 21 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
This is a single-arm, 12-week pilot study evaluating the effects of a chickpea pasta on gut microbiome diversity, gastrointestinal health, and blood biomarkers. The study will involve 12 participants consuming the test product five times per week, with questionnaires, microbiome testing, blood testing, and waist measurements collected at defined timepoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Chickpea Pasta | The intervention is intended to assess the effects of a high-fiber, legume-based dietary product on gut microbiome diversity, gastrointestinal function, and metabolic biomarkers. |
Timeline
- Start date
- 2025-02-20
- Primary completion
- 2025-07-30
- Completion
- 2025-07-30
- First posted
- 2025-12-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07264465. Inclusion in this directory is not an endorsement.